Complex Track News Today

We always look forward to the thoughtful and data-rich report National Appeals Division (NAD) issues each year summarizing the work it has accomplished in the past year. Some of the...

While pharmaceutical companies are most familiar with roles of the Food and Drug Administration (FDA)'s Office of Prescription Drug Promotion (OPDP) and Federal Trade Commission, prescription drug-focused companies may now also want to anticipate increased scrutiny of advertising by competitors.

For the umpteenth time in recent years, T-Mobile and Verizon faced off in a case of misleading 5G advertising, with no clear winner proclaimed this time around.

Advertising arbiter BBB National Programs supported some of Verizons 5G claims, but found others were non-actionable puffery.